Literature DB >> 15519162

A DFT-based QSARs study of protoporphyrinogen oxidase inhibitors: phenyl triazolinones.

Li Zhang1, Jian Wan, Guangfu Yang.   

Abstract

The equilibrium geometries, electronic structures, and electrostatic potentials of a series of substituted phenyl triazolinones, a kind of important protoporphyrinogen oxidase (Protox) inhibitors, had been investigated using density functional theory (DFT) method at the B3LYP/6-31G(d,p) basis set. The quantum chemical descriptors, such as energy difference (DeltaE) between the lowest unoccupied molecular orbital and the highest occupied molecular orbital, electrophilic and nucleophilic frontier electron density (f(i)(E) and f(i)(N)), and net atomic charge (Q(i)), were computed at the same DFT level. Based on these useful quantum chemical descriptors, the quantitative structure-activity relationships was carried out and the results showed that descriptors, Q(C11), f(N5)(E), f(C10)(N), f(O6)(E), f(C11)(N), and DeltaE, were most likely to be responsible for the in vitro biological activity and the greenhouse pre-emergence activity of phenyl triazolinones. The descriptors accounted for 77-86% of the variation in the in vitro biological activity among the herbicidal phenyl triazolinone analogs 1-26 (except compounds 19 and 20). The results of the regression analysis showed that the activity was parabolically related not only with the descriptor f(O6)(E), but also with the descriptor f(C11)(N) . The optimum values of the terms f(O6)(E) and f(C11)(N) were about 11.15 and 0, respectively. Studies also showed that compound 19 exhibiting the highest in vitro activity mimicked the three-ring portion of protoporphyrinogen IX (Protogen). The present work had proved that the DFT-based quantum chemical descriptors could lead to the better correlation relationship than that the PM3-based electronic descriptors, therefore, DFT-based QSARs could be expected to help facilitate the design of additional substituted phenyl triazolinone derivatives of Protox inhibitors with good biological activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519162     DOI: 10.1016/j.bmc.2004.08.046

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  A QSAR study of radical scavenging antioxidant activity of a series of flavonoids using DFT based quantum chemical descriptors--the importance of group frontier electron density.

Authors:  Ananda Sarkar; Tapas Ranjan Middya; Atish Dipnakar Jana
Journal:  J Mol Model       Date:  2011-11-13       Impact factor: 1.810

2.  Antioxidant activity of flavonoids: a QSAR modeling using Fukui indices descriptors.

Authors:  Houria Djeradi; Ali Rahmouni; Abdelkrim Cheriti
Journal:  J Mol Model       Date:  2014-10-14       Impact factor: 1.810

3.  DFT and GA studies on the QSAR of 2-aryl-5-nitro-1H-indole derivatives as NorA efflux pump inhibitors.

Authors:  Yujie Dai; Xu Zhang; Xiuli Zhang; Huanjie Wang; Zhansheng Lu
Journal:  J Mol Model       Date:  2008-06-25       Impact factor: 1.810

4.  Docking and 3D-QSAR studies of acetohydroxy acid synthase inhibitor sulfonylurea derivatives.

Authors:  Kunal Roy; Somnath Paul
Journal:  J Mol Model       Date:  2009-10-20       Impact factor: 1.810

5.  Docking and 3D QSAR studies of protoporphyrinogen oxidase inhibitor 3H-pyrazolo[3,4-d][1,2,3]triazin-4-one derivatives.

Authors:  Kunal Roy; Somnath Paul
Journal:  J Mol Model       Date:  2009-06-19       Impact factor: 1.810

6.  Synthesis and biological activity of novel phenyltriazolinone derivatives.

Authors:  Qiongyou Wu; Guodong Wang; Shaowei Huang; Long Lin; Guangfu Yang
Journal:  Molecules       Date:  2010-12-09       Impact factor: 4.411

7.  Theoretical Reactivity Study of Indol-4-Ones and Their Correlation with Antifungal Activity.

Authors:  María de Los Ángeles Zermeño-Macías; Marco Martín González-Chávez; Francisco Méndez; Rodolfo González-Chávez; Arlette Richaud
Journal:  Molecules       Date:  2017-03-08       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.